(Q37598903)

21 August 2017

Long-term outcome in adults with obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

21 August 2017

0 references

author

Christopher Pittenger

object named as

Christopher Pittenger

12

0 references

author name string

Michael H Bloch

1

1 reference

21 August 2017

Christy Green

2

1 reference

21 August 2017

Stephen A Kichuk

3

1 reference

21 August 2017

Philip A Dombrowski

4

1 reference

21 August 2017

Suzanne Wasylink

5

1 reference

21 August 2017

Eileen Billingslea

6

1 reference

21 August 2017

Angeli Landeros-Weisenberger

7

1 reference

21 August 2017

Benjamin Kelmendi

8

1 reference

21 August 2017

Wayne K Goodman

9

1 reference

21 August 2017

James F Leckman

10

1 reference

21 August 2017

Vladimir Coric

11

1 reference

21 August 2017

26 March 2013

1 reference

21 August 2017

Depression and Anxiety

1 reference

21 August 2017

30

1 reference

21 August 2017

8

1 reference

21 August 2017

716-722

1 reference

A 2-year prospective follow-up study of the course of obsessive-compulsive disorder

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Meta-analysis of the symptom structure of obsessive-compulsive disorder

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

The assessment of anxiety states by rating

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Treatment non-response in OCD: methodological issues and operational definitions

23 August 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

23 August 2017

https://api.crossref.org/works/10.1002%2FDA.22103

Brain anatomy and chemistry may predict treatment response in paediatric obsessive--compulsive disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Epidemiology of obsessive-compulsive disorder: a world view

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

The epidemiology of obsessive-compulsive disorder in five US communities.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

The Yale-Brown Obsessive Compulsive Scale. II. Validity

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Pretreatment status and its relationship to the length of drying-out period

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Memantine augmentation for refractory obsessive-compulsive disorder.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Memantine for treatment-resistant OCD.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Glutamatergic dysfunction in OCD.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

OBSESSIONAL NEUROTICS: A LONG-TERM FOLLOW-UP.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Quality of life for patients with obsessive-compulsive disorder.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Follow-up studies in obsessional neurosis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932438

Association Testing of the Positional and Functional Candidate Gene SLC1A1/EAAC1 in Early-Onset Obsessive-compulsive Disorder

1 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FDA.22103

[Long-term catamnesis of obsessive-compulsive neuroses]

21 January 2018

1 reference

12 December 2020

Predictors of course in obsessive-compulsive disorder

1 reference

12 December 2020

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

1 reference

12 December 2020

Obsessive-compulsive disorders in Cambridgeshire. A follow-up study of up to 20 years

1 reference

12 December 2020

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

1 reference

12 December 2020

The epidemiology and differential diagnosis of obsessive compulsive disorder

1 reference

12 December 2020

A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]

1 reference

12 December 2020

[Preliminary report on the lengthy catamnesis of obsessive disorders]

1 reference

12 December 2020

[On the problem of compulsive disease with special reference to its hereditary relations]

1 reference

12 December 2020

Clinical Syndromes in Depressive States

1 reference

12 December 2020

Identifiers

DOI

10.1002/DA.22103

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

23532944

1 reference